1003377-1MG | Gastrin I | 1 mg | Peprotech | | 317.00 | | | |
| | | | | | | | |
10-365-1G | Recombinant Human Insulin | 1 g | Peprotech | | 575.00 | | | |
| | | | | | | | |
10-365-5G | Recombinant Human Insulin | 5 g | Peprotech | | 2'297.00 | | | |
| | | | | | | | |
111-45-1MG | ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human | 1 mg | Echelon Biosciences | | 301.00 | | | |
| | | | | | | | |
111-45-5MG | ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human | 5 mg | Echelon Biosciences | | 970.00 | | | |
| | | | | | | | |
1241-1 | Oxidized Glutathione (GSSG) | 1 g | BioVision | | 124.00 | | | |
| | | | | | | | |
1242-1 | Reduced Glutathione (GSH) | 1 g | BioVision | | 124.00 | | | |
| | | | | | | | |
12609 | NTA maleimide | 5 mg | AAT Bioquest | | 184.00 | | | |
| | | | | | | | |
151-25-0.5MG | Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human | 0.5 mg | Echelon Biosciences | | 310.00 | | | |
| | | | | | | | |
151-25-1MG | Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human | 1 mg | Echelon Biosciences | | 457.00 | | | |
| | | | | | | | |
151-60-1MG | C-Type Natriuretic Peptide (CNP) (1-22), human | 1 mg | Echelon Biosciences | | 420.00 | | | |
| | | | | | | | |
152-52-0.5MG | Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human | 0.5 mg | Echelon Biosciences | | 365.00 | | | |
| | | | | | | | |
152-52-1MG | Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human | 1 mg | Echelon Biosciences | | 558.00 | | | |
| | | | | | | | |
153-15-1MG | Atrial Natriuretic Peptide (ANP) (4-24), frog | 1 mg | Echelon Biosciences | | 383.00 | | | |
| | | | | | | | |
155-40-1MG | Atrial Natriuretic Peptide (ANP) Des[18-22] (4-23) amide, rat | 1 mg | Echelon Biosciences | | 310.00 | | | |
| | | | | | | | |
155-56-0.5MG | Atrial Natriuretic Peptide (1-28), rat | 0.5 mg | Echelon Biosciences | | 310.00 | | | |
| | | | | | | | |
155-56-1MG | Atrial Natriuretic Peptide (1-28), rat | 1 mg | Echelon Biosciences | | 457.00 | | | |
| | | | | | | | |
155-62-0.5MG | Atrial Natriuretic Peptide (4-28), rat / Auriculin B | 0.5 mg | Echelon Biosciences | | 310.00 | | | |
| | | | | | | | |
155-62-1MG | Atrial Natriuretic Peptide (4-28), rat / Auriculin B | 1 mg | Echelon Biosciences | | 457.00 | | | |
| | | | | | | | |
1821-25 | Heparin-Binding Peptide I | 25 mg | BioVision | | 462.00 | | | |
| | | | | | | | |
1821-5 | Heparin-Binding Peptide I | 5 mg | BioVision | | 121.00 | | | |
| | | | | | | | |
1822-25 | Heparin-Binding Peptide II | 25 mg | BioVision | | 418.00 | | | |
| | | | | | | | |
1822-5 | Heparin-Binding Peptide II | 5 mg | BioVision | | 108.00 | | | |
| | | | | | | | |
1823-25 | Heparin-Binding Peptide III | 25 mg | BioVision | | 393.00 | | | |
| | | | | | | | |